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Summary
The respiratory (tracheal) system of the Drosophila
melanogaster larva is an intricate branched network of air-
filled tubes. Its developmental logic is similar in some ways to
that of the vertebrate vascular system. We previously
described a unique embryonic tracheal tubulogenesis
phenotype caused by loss of both of the Type III receptor
tyrosine phosphatases (RPTPs), Ptp4E and Ptp10D. In Ptp4E
Ptp10D double mutants, the linear tubes in unicellular and
terminal tracheal branches are converted into bubble-like
cysts that incorporate apical cell surface markers. This tube
geometry phenotype is modulated by changes in the activity
or expression of the epidermal growth factor receptor (Egfr)
tyrosine kinase (TK). Ptp10D physically interacts with Egfr.
Here we demonstrate that the Ptp4E Ptp10D phenotype is the
consequence of the loss of negative regulation by the RPTPs
of three growth factor receptor TKs: Egfr, Breathless and
Pvr. Reducing the activity of any of the three kinases by
tracheal expression of dominant-negative mutants suppresses
cyst formation. By competing dominant-negative and
constitutively active kinase mutants against each other, we
show that the three RTKs have partially interchangeable
activities, so that increasing the activity of one kinase can
compensate for the effects of reducing the activity of another.
This implies that SH2-domain downstream effectors that are
required for the phenotype are likely to be able to interact
with phosphotyrosine sites on all three receptor TKs. We also
show that the phenotype involves increases in signaling
through the MAP kinase and Rho GTPase pathways.
 2012. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
Receptor tyrosine kinase (RTK) signaling controls cell
proliferation and orchestrates the assembly of cells into organs
during embryonic development. Most receptors for mitogenic
growth factors are RTKs. The activities of these RTKs are tightly
regulated in adult animals, so as to permit only those cell
divisions that are necessary for organ maintenance. Cancer cells,
which escape from normal growth control mechanisms, often
display dysregulated growth factor receptor TK activity due to
mutation or overexpression of RTK genes.
RTKs are usually dimerized by ligand binding, which brings the
kinase domains into proximity and allows transphosphorylation
of each cytoplasmic domain by the kinase of its partner.
Transphosphorylation creates docking sites for phosphotyrosine
(PTyr)-binding SH2-domain effectors, and can also increase
kinase activity through phosphorylation-induced conformational
changes. In some cases, binding to the RTK serves only to
relocalize an effector to the plasma membrane, while in other cases
the RTK phosphorylates the bound effector and alters its activity.
RTKs interact with many different effectors and transmit signals
through many different pathways.
RTK signaling is regulated by protein tyrosine phosphatases
(PTPs), which dephosphorylate the RTKs themselves as well as
their substrates (reviewed by Tonks, 2006). PTP activity is
normally in excess over TK activity, and chemical inhibition of
PTPs causes dramatic increases in cellular PTyr content, far
beyond those that can be produced by overexpressing any TK (for
an example, see Bugga et al., 2009). It is generally thought that
the enzymes that maintain PTyr at low levels in the cell are
cytoplasmic PTPs, while receptor PTPs (RPTPs), which are
transmembrane proteins, regulate signaling by specific
membrane-associated TKs.
There are 19 RPTPs encoded in the human genome, four of
which are classified as Type III. Type III RPTPs are
characterized by extracellular (XC) domains composed of
chains of fibronectin type III repeats attached to single
cytoplasmic PTP domains. Biochemical and genetic studies
have suggested that Type III RPTPs are regulators of RTK
activity, although they also have other targets (reviewed by
Matozaki et al., 2010). ‘Substrate-trapping’ mutants (Flint et al.,
1997) of Type III RPTPs, which bind to target PTyr sites but
cannot complete the dephosphorylation reaction, form stable
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complexes with RTKs, suggesting that RTKs are direct targets
for RPTP enzymatic activity.
One Type III RPTP, PTPRJ (DEP-1/CD148/R-PTP-eta)
regulates a variety of growth factor receptors, including the
epidermal growth factor receptor (EGFR), the platelet-derived
growth factor receptor (PDGFR), the vascular-endothelial growth
factor receptor (VEGFR), and the colony stimulating factor-1
receptor (CSF1R or MET), among others (Arora et al., 2011;
Berset et al., 2005; Chabot et al., 2009; Lampugnani et al., 2003;
Kappert et al., 2007; Palka et al., 2003; Tarcic et al., 2009).
Negative regulation of these and other PTPRJ targets may be
important for tumor suppression, because mouse PTPRJ
corresponds to the Suppressor of colon cancer1 (Scc1) gene
(Ruivenkamp et al., 2002). Two other Type III RPTPs, PTPRB
(VE-PTP) and PTPRO, negatively regulate the angiopoietin
receptor Tie-2 and the NT-3 receptor TrkC, respectively (Hower
et al., 2009; Winderlich et al., 2009).
Drosophila has provided a valuable system in which to
investigate RPTP function, because its genome encodes only six
RPTPs, and three of these (Lar, Ptp69D, Ptp52F) have single-
gene loss-of-function (LOF) phenotypes affecting axon guidance
and synaptogenesis (reviewed by Johnson and Van Vactor,
2003). There are two Type III RPTPs in Drosophila, Ptp4E and
Ptp10D, which are closely related, being the products of a recent
gene duplication (Jeon et al., 2008). Ptp4E is widely expressed
during embryogenesis (Jeon et al., 2008; Oon et al., 1993), while
Ptp10D is restricted to central nervous system axons and the
tracheal system (Jeon and Zinn, 2009; Tian et al., 1991; Yang et
al., 1991). Ptp4E and Ptp10D single mutants are viable and
fertile, and have no detectable embryonic defects (Jeon et al.,
2008; Sun et al., 2000). Ptp4E Ptp10D double mutants, however,
die at the end of embryogenesis due to respiratory failure. They
display a unique tracheal phenotype in which unicellular and
terminal branches develop bubble-like cysts in place of their
normal tubular lumens (Jeon and Zinn, 2009). This phenotype
may have never been found in genetic screens for mutations
causing tracheal defects because it requires the loss of both
RPTPs. There may also be no single component downstream of
the RPTPs that could be mutated to generate this phenotype,
since the RPTPs are likely to regulate multiple RTK signaling
pathways.
In our previous paper, we characterized the cell biology of the
Ptp4E Ptp10D phenotype in detail. A unicellular tracheal tube
has a lumen that is surrounded by the apical surface of a single
cell (for reviews of tracheal tubulogenesis, see Affolter and
Caussinus, 2008; Ghabrial et al., 2011; Swanson and Beitel,
2006). Ptp4E and Ptp10D are apically localized in tracheae (Jeon
and Zinn, 2009). In Ptp4E Ptp10D mutants, apical membrane
markers that are normally localized to the lumen appear in the
cysts. EM analysis demonstrated that the cysts in unicellular
branches are extracellular compartments with adherens junctions,
and are therefore distorted and enlarged versions of normal
tubular lumens. We hypothesized that the phenotype arises
because the apical actin cytoskeleton fails to interact correctly
with the apical membrane during the cell remodeling processes
that accompany tube formation in unicellular branches. These
interactions would normally constrain the lumen into a
cylindrical shape, and the interaction defects in the mutants
result in the generation of spherical cysts in place of tubes.
Interestingly, terminal branches, which contain ‘seamless’ tubes
(lacking adherens junctions) within cells, also develop cysts
(Jeon and Zinn, 2009). In terminal cells, apical membrane grows
inward to form an intracellular lumen (Gervais and Casanova,
2010). This new apical membrane aligns along cytoskeleton
elements, so the geometry of the seamless tubes might be altered
by the same types of membrane-cytoskeleton interaction defects
that affect tube formation in unicellular branches.
The Ptp4E Ptp10D phenotype involves a loss of negative
regulation of the Egfr ortholog, and Ptp10D physically associates
with Egfr. Further elevation of Egfr activity by tracheal
expression of a constitutively activated (CA) Egfr mutant in the
Ptp4E Ptp10D background causes cyst expansion, as does
expression of a CA mutant of Drosophila Raf kinase, a MAP
kinase pathway component which is downstream of Egfr (Brand
and Perrimon, 1994). However, expression of CA mutants of Egfr
or Raf in a wild-type background does not generate any cysts
(Jeon and Zinn, 2009).
There are four clear growth factor receptor TK orthologs in
Drosophila, three of which are expressed in tracheal cells during
embryogenesis. These are: Egfr, Breathless (Btl; FGFR ortholog)
and Pvr (PDGFR/VEGFR/CSF1R ortholog) (Cela and Llimargas,
2006; Cho et al., 2002; Glazer and Shilo, 1991) (for a review of
Drosophila RTK gene sequences, see Morrison et al., 2000); also
see http://bio.illinoisstate.edu/kaedwar/Flycellbio/PTKandPTPlists.
shtml. In our earlier paper, we showed that cyst size in Ptp4E
Ptp10D mutants is increased by expression of a CA mutant of Btl
and decreased when one copy of wild-type Btl is removed,
suggesting that hyperactivation of Btl might also contribute to the
phenotype (Jeon and Zinn, 2009). In this paper, we analyze genetic
interactions between all three growth factor RTKs and the Type III
RPTPs by simultaneously expressing dominant-negative (DN) and
CA RTK constructs in tracheal cells. We evaluate the effects of
these constructs on Ptp4E Ptp10D cyst phenotypes on four different
tracheal branches, and find that RTK perturbations affect each
branch in a different manner. Our data show that all three RTKs are
involved in determination of tube geometry, and that they have
partially interchangeable activities. An increase in the activity of one
RTK can compensate for a reduction in the activity of another.
We also examine genetic interactions between the RTKs and
two downstream signaling pathways, the Ras/MAP kinase
pathway and the Rho pathway. Both are involved in the tube
formation processes that are affected in the Rptp double mutant.
Materials and Methods
Fly stocks and genetics
The following Drosophila stocks were obtained from the Bloomington Stock
Center (Bloomington, IN, USA): UAS-EgfrElp, UAS-EgfrDN, UAS-Phl-CA, UAS-
InR-R418P, UAS-Rho1V14, UASRho1N19, UAS-Rac1, UAS-Rac1V12, UAS-
Rac1N17, UAS-Cdc42V12, UAS-Cdc42N17, UAS-mCD8GFP. UAS-lBtl, UAS-
BtlDN, Btl-GAL4 were kindly provided by M. Krasnow (Stanford University,
Stanford, CA, USA), and UAS-lPvr, UAS-PvrDN were kindly provided by P.
Rorth (IMCB, Singapore). Ptp4E1Ptp10D1/FM7-GFP; Btl-GAL4 female flies were
crossed to UAS-transgenic male flies and progeny were examined for genetic
interactions. All crosses were carried out at 25 C˚.
To verify the presence of transgenes, PCR was used to amplify the regions
spanning the deleted domains in dominant negative constructs UAS-EgfrDN
(FlyBase, personal communication), UAS-BtlDN (Reichman-Fried and Shilo,
1995), UAS-PvrDN (Duchek et al., 2001). Primers were designed to amplify the l
dimerization domains in UAS-lBtl (Lee et al., 1996) and UAS-lPvr (Duchek et al.,
2001). UAS-EgfrElp and UAS-Phl-CA were recognized using forward primers that
annealed to the corresponding genes and reverse primers that recognized the
pUAST and pUASP vectors, respectively. The following primer pairs were used:
EgfrElp (forward 59-GTTAGTGTGGACAATCCGG, reverse 59-TTGTCCAATT-
ATGTCACACCAC), lBtl (forward 59-GCCCATGGTTACCTGGAGG, reverse
59-CAGCCGACGCAGCATGAACG), lPvr (forward 59-GCCCATGGTTACCT-
GGAGG, reverse-59-TCCTCGAAGTTGGCCAATCC), EgfrDN (forward 59-
TACTGTGCAGCTAGTCCGC, reverse 59-TTGTCCAATTATGTCACACCAC),
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BtlDN (forward 59-GTCTACTCTGATCTGCATCC, reverse 59-TTGTCCAA-
TTATGTCACACCAC), PvrDN (forward 59-TCTGCTGGGCAACATTTCCG,
reverse 59-TGGTGCTATGTTTATGGCGC), Phl-CA (forward 59-CATTGAAGC-
GCTTGGCCG, reverse 59-TGGTGCTATGTTTATGGCGC).
Immunohistochemistry and microscopy
A standard protocol as reported in (Jeon et al., 2008) was used for whole-mount
antibody staining of stage 15 embryos. The following primary antibodies were
used: monoclonal antibody (mAb) 8B2 against Ptp10D [1:3; Developmental
Studies Hybridoma Bank (DSHB)], mAb 4G10 against pTyr (1:300; Millipore),
and rabbit or chicken anti-GFP (1:1000; Invitrogen), mAb Cq4 against Crb [1:3;
Developmental Studies Hybridoma Bank (DSHB)], mAb DCAD2 against DE-
cadherin [1:3; Developmental Studies Hybridoma Bank (DSHB)]. Rabbit anti-Sas
(1:1000) was kindly provided by D. Cavener (Vanderbilt University, TN, USA).
Secondary antibodies used were goat anti-mouse, goat anti-rabbit, and goat-anti-
chicken antibodies coupled to Alexa Fluor 488, 568, or 594 (1:1000; Invitrogen).
20–40 dissected embryos were mounted per slide in 10 ml of Vectashield (Vector
Laboratories) using 22622 mm coverslip. Images were acquired on an inverted
laser scanning confocal miscroscope (DMIRE2; Leica) using 406 objective lens.
Images were processed using Adobe Photoshop.
Quantification of tracheal phenotypes
Fixed and stained stage 15 embryos were dissected according to protocols
described in http://www.its.caltech.edu/,zinnlab/motoraxons/protocols.html.
Samples were imaged using confocal microscopy and z-stack projections were
obtained. Measurements were made according to protocols described in (Jeon and
Zinn, 2009). Tr4-7 segments had equivalent phenotypes, so we pooled data from
these segments. We measured or counted cysts in Tr4-7 segments for at least five
embryos for each genotype. Error bars in figures were obtained by calculating the
standard error of the mean using the formula (s/!n; s5standard deviation,
n5sample size).
Results
Three growth factor receptor tyrosine kinases participate in
tracheal tube formation
To analyze genetic interactions between the Type III RPTPs and
growth factor RTK orthologs, we used CA and DN transgenes for
Egfr, Btl, and Pvr. The Egfr-CA transgene carries the Elp
mutation, which changes a single amino acid in the cytoplasmic
domain and generates a constitutively active receptor (Lesokhin
et al., 1999). The CA Btl and Pvr constructs were engineered with
a lambda receptor dimerization domain in the N-terminus that
forces ligand-independent dimerization, thereby activating the
receptors (Duchek et al., 2001; Lee et al., 1996).
The DN versions of all three receptors are cytoplasmic (kinase)
domain deletions. DN RTK mutants were devised about 20 years
ago (Amaya et al., 1991; Kashles et al., 1991), and have since been
used in hundreds of papers, primarily in vertebrate systems, to
selectively inhibit specific RTKs. When expressed at high levels,
these DN mutants reduce or eliminate RTK activity by dimerizing
with wild-type receptors in a ligand-dependent manner, producing
inactive complexes that cannot undergo transphosphorylation
because they have only one kinase domain. To ensure signaling
specificity, RTK XC domains have evolved to dimerize only with
themselves or with specific heterodimeric partners within the same
family, so DN mutants are highly selective inhibitors of the RTK
families from which they are derived. The three RTK-DN mutants
used in this paper have been employed by many groups to perturb
development of a variety of different tissue and organs in
Drosophila. They have been repeatedly shown to produce
phenotypes that match those of LOF mutations of the same RTK,
thereby demonstrating that they have the appropriate specificities
(Buff et al., 1998; Cela and Llimargas, 2006; Duchek et al., 2001;
Kumar and Moses, 2001; Nagaraj et al., 1999; Reichman-Fried and
Shilo, 1995; Scholz et al., 1997; Szu¨ts et al., 1997).
The three DN mutants are capable of generating null or near-
null phenotypes when expressed early in tissue development, so
that they can block the activity of newly synthesized wild-type
RTK in that tissue. However, when expressed after wild-type
RTK has been made and executed some of its functions, they
produce weaker phenotypes. Most relevant to the present paper,
(Reichman-Fried and Shilo, 1995) showed that early expression
of DN Btl from heat-shock-GAL4 blocks all branch migration,
while later heat shock produces weaker phenotypes that affect
only specific branches. In this paper, we are expressing DN Btl
(and other RTK mutants) from the Btl-GAL4 driver, so it comes
on later than the onset of wild-type Btl expression due to the time
lag associated with the GAL4 regulatory circuit. The phenotypes
we observe affect extension of specific branches, but no branches
are missing (see Fig. 1). Similarly, we observe subtle tissue
integrity phenotypes for DN Egfr that match those seen by (Cela
and Llimargas, 2006), who also drove expression in tracheae
using Btl-GAL4. By contrast, Egfr null mutant embryos, which
lack all zygotically synthesized Egfr, have severe tracheal defects
(Cela and Llimargas, 2006).
We first characterized the effects of the RTK transgenes when
they were driven by the tracheal-specific Btl-GAL4 driver in a
wild-type (w1118) background (Btl.RTK-DN or Btl.RTK-CA).
In all figures in this paper, the tracheal system was labeled using
an antibody against the apical cell surface protein Stranded at
second (Sas) (Schonbaum et al., 1992). The strongest DN
phenotype was produced by the Btl-DN transgene. This caused
defects in ganglionic branch (GB) extension, so that many GBs
failed to extend to the ventral nerve cord (VNC) in stage 15
embryos (Fig. 1C). Egfr-DN caused a weaker GB extension
defect, in which all GBs grew but some were shorter than in wild-
type (Fig. 1B). Pvr-DN did not generate any obvious phenotypes
(Fig. 1D).
In stage 15 wild-type embryos, there are usually two terminal
branches (Fig. 1A, arrow) extending away from each lateral trunk
(LT) segment. In embryos expressing Egfr-CA or Btl-CA, there
were many extra terminal branches along each LT (Lee et al.,
1996) (Fig. 1E,F, arrows). Ectopic terminal branches were also
observed along the visceral branch (VB), which was dissected
away in the embryos shown in Fig. 1. There were also occasional
ectopic unicellular branches attached to the dorsal trunk (DT)
(Fig. 1E, asterisk) and the GB. Pvr-CA produced no visible
tracheal phenotypes.
We then combined each DN transgene with the Ptp4E1
Ptp10D1 double null mutation, to generate Ptp4E Ptp10D,
Btl.RTK-DN embryos. Ptp4E Ptp10D double mutant embryos
have cysts instead of tubes at all transverse connective (TC)/LT
junctions (Fig. 1H, arrowheads), resulting in a .2-fold increase
in average TC/LT junction diameter relative to wild-type
(Fig. 1O). As in our previous paper, we quantitatively analyzed
the effects of the transgenes on the cyst phenotype by measuring
the diameters of these junctions. Three different Egfr
manipulations (Egfr-DN, removing one copy of wild-type Egfr,
and a tracheally expressed Egfr dsRNA (RNAi) transgene)
partially or completely suppress the increase in TC/LT junction
diameter (Jeon and Zinn, 2009). Here we compared three
different RTK-DN transgenes in the same set of experiments,
and observed that all three transgenes completely suppressed the
TC/LT diameter increase phenotype (Fig. 1O). Btl-DN and Pvr-
DN eliminated all cysts in the TC/LT region (Fig. 1J,K), while
small cysts were still present with Egfr-DN (Fig. 1I). These data
show that a reduction in activity of any of the three RTKs
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suppresses the TC/LT phenotype produced by loss of negative
regulation by the Type III RPTPs.
Expressing Egfr-CA from the Btl-GAL4 driver in the Ptp4E
Ptp10D background produced a dramatic enhancement of the
TC/LT phenotype, generating huge cysts (some are .20 mm in
diameter) at TC/LT junctions (Fig. 1L). Here we compared the
effects of expressing the three growth factor RTK-CA transgenes,
as well as a CA transgene for the Drosophila insulin receptor
(InR), in the Ptp4E Ptp10D background. Egfr-CA, Btl-CA, and
Pvr-CA-expressing embryos all had expanded cysts at TC/LT
junctions (Fig. 1L–N). InR-CA, however, did not enhance the
Ptp4E Ptp10D phenotype, and in fact produced a slight decrease
in TC/LT junction diameter (Fig. 1O).
These data show that all three growth factor RTKs are
involved in the Ptp4E Ptp10D phenotype, and suggest that this
phenotype might be caused by simultaneous increases in the
activities of multiple RTKs. If so, perhaps one could generate a
Ptp4E Ptp10D-like cystic phenotype in a wild-type background
by expressing multiple RTK-CA transgenes in tracheal cells
using Btl-GAL4. We tested this idea by expressing Egfr-CA+Btl-
CA, Egfr-CA+Pvr-CA, and Btl-CA+Pvr-CA. However, none of
these manipulations produced any cysts, and there was no
increase in TC/LT junction diameter over wild-type (Fig. 1O).
We also expressed all three transgenes together (Egfr-CA+Btl-
CA+Pvr-CA). Because of the genetic manipulations necessary to
make triple transgene embryos bearing the Btl-GAL4 driver, we
could not obtain enough of these embryos to perform a
quantitative analysis of TC/LT diameter, but it was clear that
they did not have Ptp4E Ptp10D-like cystic phenotypes (data not
shown).
Competing receptor tyrosine kinase mutants against each other
Having demonstrated that all three RTKs influence the Ptp4E
Ptp10D phenotype, we now wished to ask if each RTK is
uniquely required for the phenotype, or if they can substitute for
each other. We evaluated this by simultaneously expressing DN
and CA RTK transgenes in the Ptp4E Ptp10D background and
determining the effects of these manipulations on TC/LT junction
diameter. The results described above show that DN mutants of
each RTK suppress the Ptp4E Ptp10D cyst phenotype. If the
generation of the phenotype requires binding of SH2-domain
effectors that can interact with only one phosphorylated RTK,
then expressing a DN mutant of one RTK in the presence of a CA
mutant of another RTK should still cause complete or almost-
complete suppression, returning the embryos to a near-wild-type
TC/LT phenotype. On the other hand, if the relevant effectors can
bind to PTyr residues on two or more RTKs, the CA mutant
should partially rescue the suppression caused by the DN mutant,
returning the phenotype to the strength of unmodified Ptp4E
Ptp10D.
We examined five of the six possible CA/DN combinations (we
could not make Egfr-CA+Btl-DN because of the chromosomal
positions of the transgene insertions). In contrast to their ability to
suppress the TC/LT diameter phenotype in Ptp4E Ptp10D
embryos to wild-type values (Fig. 1O), none of the DN mutants
was able to suppress a Ptp4E Ptp10D, Btl.RTK-CA phenotype
back to wild-type (Fig. 1P). For three of the five combinations, the
phenotype was approximately the same as in unmodified Ptp4E
Ptp10D embryos. The other two combinations (Btl-CA+Egfr-DN
and Pvr-CA+Egfr-DN) exhibited somewhat stronger suppression,
generating phenotypes that were intermediate between wild-type
and Ptp4E Ptp10D (Fig. 1P). Based on these results, we conclude
that none of the three RTKs is uniquely required to generate the
Ptp4E Ptp10D cyst phenotype. This conclusion is strengthened by
phenotypic analysis of the GB.
Effects of kinase activity manipulations on other
tracheal branches
To quantitatively analyze the effects of kinase manipulations on
the unicellular GB, we counted GB cysts. All GBs in Ptp4E
Ptp10D embryos had cysts (Fig. 1H), but they were never
observed in wild-type embryos, or in embryos where any of the
Fig. 1. Effects of dominant-negative and constitutively activated receptor
tyrosine kinase mutants on tracheal tube formation. In all panels, the
tracheal system was labeled in stage 15 embryos using an antibody against the
apical cell-surface protein Sas. Three hemisegments are shown in each panel,
with dorsal up and anterior to the left. In all panels, the DT is the large
horizontal tube, with DBs extending upwards from it and TCs extending down.
The GBs are the thin vertical branches at the bottom of each panel (B, arrows).
The tracheal-specific driver Btl-GAL4 was used to express all mutant UAS-
RTK constructs. When DN constructs were expressed in the wild-type (w1118)
background (A), we observed shortening of GBs with Egfr-DN (B, arrows);
missing GBs (C, arrow) and GBs that failed to extend (C, line) with Btl-DN;
and relatively normal tracheae with Pvr-DN (D). With CA Egfr and Btl, ectopic
branches were observed, including extra terminal branches along the LT
(terminal branches indicated by arrows in A,E,F,G) and ectopic DBs (E,
asterisk). Pvr-CA was indistinguishable from wild-type. In Ptp4E Ptp10D
(4E10D) mutants, cysts were observed at all TC/LT junctions (H, arrowheads),
and along the GBs (the three bottom branches in H). DN RTKs produced strong
suppression of the TC/LT cyst phenotype (I–K, arrowheads). GB cysts were
still present with Egfr-DN, while there were fewer with Btl-DN and Pvr-DN
(J,K, arrows) (see Fig. 2F for quantitation). Brackets in (J,K) indicate GB
regions with weak or absent staining for the apical marker. As in the wild-type
background, there were shorter GBs with Egfr-DN and missing GBs with Btl-
DN (J, line). Enhancement of the TC/LT junction phenotype (L–N,
arrowheads) was observed with all three RTK CA mutants. The strongest
enhancement was seen with Egfr-CA, which also produced numerous cysts on
DBs (L, arrow) (see Fig. 3F for quantitation). (O) Quantitative analysis of cyst
phenotypes produced by DN or CA RTK constructs. The diameters of TC/LT
junctions in segments Tr4-7 were measured at the points indicated by the
arrowheads. (P) Quantitative analysis of RTK competition experiments. Error
bars in all figures indicate the standard error of the mean (see Materials and
Methods for formula). Scale bar: 20 mm.
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three CA RTK mutants were expressed in a wild-type
background. Egfr-CA and Pvr-CA both enhanced the Ptp4E
Ptp10D GB cyst phenotype, increasing cyst number by ,1.5-fold
(Fig. 2F) and also increasing cyst diameters (not quantitated;
compare Fig. 2A and Fig. 2E). Btl-CA did not significantly
enhance the Ptp4E Ptp10D phenotype. When we examined the
DN mutants, we found that they had somewhat different effects
from those seen for the TC/LT phenotype (Fig. 1). Btl-DN almost
completely suppressed the phenotype, decreasing cyst numbers to
almost zero. However, Pvr-DN only produced a ,1.5-fold
decrease, and Egfr-DN did not affect cyst number (Fig. 2F).
The DN mutant results might be interpreted as suggesting that
there is a unique requirement for Btl activity for generation of GB
cysts. However, when we examined embryos in which Btl-DN
was expressed together with Pvr-CA, we found that the
phenotype was suppressed only back to that of unmodified
Ptp4E Ptp10D embryos (Fig. 2F). Thus, Pvr was able to
substitute for Btl when Pvr activity levels were increased, even
though the presence of wild-type Pvr could not prevent Btl-DN
from completely suppressing the GB cyst phenotype of Ptp4E
Ptp10D embryos.
The unicellular DB displays a different dependence on RPTP
and RTK function than the GB. DB cysts are rare in Ptp4E
Ptp10D mutants (only about 30% of DBs have any cysts), and are
common only in Ptp4E Ptp10D, Btl.Egfr-CA embryos
(Fig. 3B,F). The other two CA mutants did not enhance the
Ptp4E Ptp10D DB phenotype.
All three DN mutants completely suppressed the Ptp4E
Ptp10D DB cyst phenotype (Fig. 3C,F). However, Pvr-DN only
produced a slight suppression of the enhanced Ptp4E Ptp10D,
Btl.Egfr-CA phenotype, indicating that loss of Pvr activity
cannot prevent excess Egfr activity from increasing cyst number
on the DB (Fig. 3F).
To evaluate the effects of RTK manipulations on seamless
(intracellular) tubes, we examined the LG terminal branch.
Although seamless tubes are created by the inward growth of
membrane into terminal cells (Gervais and Casanova, 2010), they
also have apical membrane lining the lumen, suggesting that
there may be parallels between the mechanisms of formation of
seamless and unicellular tubes. In seamless tubes, a new apical
compartment is created within the cell, while the existing apical
side of a cell becomes the luminal face of a unicellular tube (for
reviews, see Affolter and Caussinus, 2008; Swanson and Beitel,
2006).
We performed a qualitative assessment of the effects of the
kinase manipulations on this branch, because the number of LG
tubes is variable, making it difficult to count cysts. All of the CA
RTK mutants enhanced the phenotype, creating larger cysts
(compare Fig. 4A and Fig. 4D). As for the GB, Btl-DN produced
complete suppression of the cyst phenotype (Fig. 4C), while the
other two DN mutants had relatively little effect. However, Btl-
DN could not completely suppress the cyst phenotype in Ptp4E
Ptp10D, Btl.Pvr-CA embryos, indicating that, as for the GB and
Fig. 2. Effects of DN and CA RTK mutant constructs on the GB cyst
phenotype. Magnified images of single GBs stained with anti-Sas are shown in
panels (A–E). Yellow lines indicate the beginning and the end of each GB, and
orange arrowheads indicate GB cysts. Strong suppression of the Ptp4E Ptp10D
phenotype was observed only for Btl-DN (C). Egfr-CA produced strong
enhancement for both cyst number and diameter (E). (F) Quantitative analysis
of the GB cyst number phenotype.
Fig. 3. Effects of RTK, Raf (Phl), and Rho mutant constructs on the DB
cyst phenotype. Magnified images of DBs in three hemisegments stained with
anti-Sas are shown in panels (A–E); cysts are indicated by arrows.
Enhancement of the Ptp4E Ptp10D phenotype was observed for Egfr-CA (B),
Phl-CA (D), and Rho1-CA (E). All DN RTKs produced strong suppression of
the phenotype (shown for Egfr-DN in C). (F) Quantitative analysis of the DB
cyst phenotype. Because DB cysts are rare in most genotypes, we scored the
percentage of DBs that displayed any cysts rather than counting cysts. Scale
bar: 10 mm.
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TC/LT phenotypes, increased activity of Pvr can compensate for
the loss of Btl activity.
Localized accumulation of phosphotyrosine in Ptp4E Pt10D
mutant embryos
Since Ptp4E and Ptp10D appear to allow normal tube formation
by negatively regulating RTK activity, we wondered if PTyr
levels in the tracheal system might be increased in the absence of
these RPTPs. To evaluate this idea, we double-stained stage 14
embryos with anti-PTyr and anti-Sas. Anti-PTyr outlines the
entire tracheal system in wild-type embryos (Fig. 5B). The
overall intensity of anti-PTyr staining was not changed in Ptp4E
Ptp10D embryos (data not shown). This suggests that other PTPs,
probably widely expressed cytoplasmic PTPs, are responsible for
setting the overall levels of PTyr.
We observed revealing local changes in PTyr in Ptp4E Ptp10D
embryos. PTyr levels were low in wild-type GB cells, but there
was a hotspot of labeling at junctions between the cells (Fig. 5E,
arrowheads). Ptp4E Ptp10D GB cells that had cysts displayed
bright anti-PTyr staining on the apical membrane that surrounds
the lumen of the cyst (Fig. 5H, arrowhead). This staining might
be due to elevated activity of one or more of the RTKs that are
regulated by Ptp4E and Ptp10D.
The MAP kinase pathway is involved in generation of the Ptp4E
Ptp10D cyst phenotype
To evaluate the role of Ras/MAP kinase signal transduction,
which is downstream of RTKs, we expressed a constitutively
activated mutant of Drosophila Raf (also known as Pole hole or
Phl), called Phl-CA (Brand and Perrimon, 1994), in the tracheae
using Btl-GAL4. Raf/Phl is a serine/threonine kinase that is an
effector for Ras. It is also called MAP kinase kinase kinase
(MAPKKK), and is the first enzyme in the MAP kinase cascade.
Expression of Phl-CA in a wild-type background did not generate
any cysts, but it was able to enhance the TC/LT cyst phenotype
when expressed in the Ptp4E Ptp10D background (Fig. 6A,E).
Like Egfr-CA, Phl-CA enhanced the DB cyst phenotype
(Fig. 3D,F), but it did not produce a major increase in the
number of GB cysts.
If elevated RTK activity produces the cyst phenotype solely
via increased signaling through the MAP kinase pathway, one
might expect that expressing DN RTKs together with Phl-CA in
the Ptp4E Ptp10D background would not suppress the Phl-CA-
enhanced phenotype, since RTKs are upstream of Raf. On the
other hand, if other signaling pathways downstream of RTKs
must also be overactivated to generate cysts, then DN RTKs
might be expected to suppress the Ptp4E Ptp10D, Btl.Phl-CA
phenotype. The actual results observed were that Egfr-DN and
Btl-DN affected the phenotype in the same manner as they
altered Ptp4E Ptp10D, Btl.RTK-CA phenotypes: that is, they
suppressed the phenotype back to approximately the same
strength as that of unmodified Ptp4E Ptp10D (Fig. 6E).
Suppression by Pvr-DN was very weak (at the margin of
statistical significance).
The relative contributions of MAP kinase signaling vs. other
pathways to the cyst phenotype, and the extent to which each of
the RTKs drives signaling through each pathway, cannot easily
be determined from these data, since we do not know how
strongly MAP kinase signaling is activated by Phl-CA vs. the
RTK-CA constructs. The major conclusion from the Egfr-DN and
Btl-DN suppression of the Phl-GOF enhancement is that
Fig. 4. Effects of RTK and Raf (phl) mutant constructs on the LG
(terminal branch) cyst phenotype. Each panel shows the LG branches in a
single hemisegment, stained with anti-Sas. Lines indicate the points where the
LGs branch from the LT, and arrows indicate LG cysts. In stage 15 Ptp4E
Ptp10D embryos, most LGs had small cysts (A). All CA RTK mutants and Phl-
CA produced larger cysts (B,D,F). Btl-DN completely suppressed the
phenotype, eliminating all cysts (C), while Egfr-DN (E) and Pvr-DN (not
shown) did not produce strong suppression. Scale bar: 5 mm.
Fig. 5. Anti-phosphotyrosine staining of the tracheal system in wild-type
and in Ptp4E Ptp10D mutants. (A–C) A wild-type (w1118) embryo at stage 14
double-stained with monoclonal antibody 4G10 against PTyr (green/white) and
anti-Sas (magenta/white). PTyr staining outlined the tracheal system at this
stage; Ptp4E Ptp10D embryos showed no changes from this pattern (not
shown). The LT, which has not fused across segment borders at this stage, is
indicated by arrowheads; a GB is indicated by an arrow. (D–I) GB cells
expressing mCD8GFP from Btl-GAL4 were visualized with anti-PTyr
(magenta/white) and anti-GFP (green/white). Nuclei are indicated by asterisks.
In wild-type, PTyr staining above baseline levels was detected at the
autocellular junction (D,E, upper arrowhead) and at the junction between the
two cells shown (D,E, lower arrowhead). (G–I) A single GB cell with a cyst is
shown in a Ptp4E Ptp10D mutant. PTyr levels were usually higher around the
entire cell than in wild-type, and cysts were outlined by high PTyr staining
(arrowhead). The cyst membrane in this cell has three PTyr hot spots. Scale
bars in (A–C): 10 mm; in (D–I): 5 mm.
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processes downstream of MAP kinase signaling are insufficient
to explain the effects of these RTKs on the cyst phenotype.
Rho GTPase signaling is required for the Ptp4E Ptp10D
cyst phenotype
Rho family GTPases are downstream of many RTKs in
mammalian systems (reviewed by Schiller, 2006). They are
activated by Rho family guanine nucleotide exchange factors
(GEFs), some of which can bind to and/or become
phosphorylated by activated RTKs. Rho family GTPases are
logical candidates for signaling molecules that mediate the
effects of Ptp4E and Ptp10D on formation of tubes in the tracheal
system, because they are known to affect cytoskeletal and
membrane compartments. The best hypothesis for the failure of
tube formation in Ptp4E Ptp10D mutants is that elevation of RTK
activity disrupts interactions between the apical membrane and
the actin cytoskeleton.
The Rho family in Drosophila includes one Rho gene, three
Rac genes, and one Cdc42 gene (reviewed by Johndrow et al.,
2004). To examine the roles of these GTPases, we expressed DN
mutants of Rho1, Rac1, and Cdc42, as well as Rho1 dsRNA
(RNAi), in wild-type and Ptp4E Ptp10D mutant tracheal cells. In
wild-type embryos, tracheal expression of Rho1-DN or Rac1-DN
caused defects in branching morphogenesis. Embryos that
expressed Rac1-DN had phenotypes in which many GBs failed
to extend to their full lengths (Fig. 7C). In Rho1-DN-expressing
embryos, GBs were full-length but some branches appeared to be
discontinuous when visualized by staining for the apical marker
Sas (Fig. 7B). Expression of Cdc42-DN caused defects in LT
fusion (data not shown), but otherwise had little effect on tracheal
branching.
In Ptp4E Ptp10D mutant embryos, we observed complete
suppression of the phenotype, as assayed by the TC/LT junction
diameter metric, when Rho1-DN or Rac1-DN was expressed.
Rho1 RNAi and Cdc42-DN produced partial suppression
(Fig. 7G). For GB cyst number, Rho1-DN (Fig. 7E,H) and
Rac1-DN produced strong (.2-fold) suppression, but Cdc42-DN
had no effect (Fig. 7F,H).
Next, we examined the effects of expressing CA mutants of
Rho1, Rac1, or Cdc42. Tracheal expression of Rac1-CA in a
wild-type background produced severe defects that prevented
assessment of interactions with the Ptp4E Ptp10D phenotype.
Wild-type embryos expressing Cdc42-CA had defects in DT and
LT fusion and failures of GB extension in many hemisegments,
and when Cdc42-CA was expressed in the Ptp4E Ptp10D
background it caused a weak suppression of the phenotype (data
not shown).
The most interesting effects were produced by Rho1-CA.
When expressed in wild-type embryos, Rho1-CA caused failure
of DT and LT fusion, and prevented GB branch extension
(Fig. 8A). In the Ptp4E Ptp10D background, Rho1-CA produced
DB cysts (Figs 3E, 8C). It also resulted in the conversion of the
TC/LT region into networks of bubble-like structures (Fig. 8B).
These bubbles are composed of apical membrane, and they also
contain regions that express adherens junctions markers
(Fig. 8D,E). We do not know whether these structures are
cysts. In some cases, adherens junction markers were localized in
circular structures surrounded by apical membrane, as in
multicellular cysts (supplementary material Fig. S1), but other
regions of apical membrane were not associated with junctional
markers.
To evaluate the potential relationships between Rho and the
RTKs, we examined interactions between Rho1-CA and DN
RTK mutants. We observed that Egfr-DN and Pvr-DN had little
effect on the enhancement of the DB cyst phenotype by Rho1-CA
(Fig. 3F). Btl-DN did suppress the effects of Rho1-CA, but it also
shortened the DB branch, so we cannot be sure that it specifically
blocked Rho1-CA-induced cyst formation. The odd bubble-like
morphology of the TC/LT region seen in Ptp4E Ptp10D,
Btl.Rho1-CA embryos was not obviously changed when any
of the DN RTK mutants was expressed (Fig. 8F–H).
Discussion
The Drosophila tracheal system is an intricate branched network
of air-filled tubes that delivers oxygen to tissues. Tube formation
in the tracheal system involves complex morphogenetic events
that differ between tube types. Multicellular tubes have lumens
that are surrounded by the apical surfaces of several cells.
Unicellular tubes are formed by rolling up of single cells to form
junctions with themselves. Seamless tubes are intracellular
structures within terminal cells. Many genes have been
identified that affect the formation and morphology of tracheal
tubes (for reviews, see Affolter and Caussinus, 2008; Ghabrial et
al., 2011; Swanson and Beitel, 2006).
The absence of the two Type III RPTPs, Ptp4E and Ptp10D,
changes the geometries of the tubes in unicellular and terminal
branches, so that they form spherical cysts in place of continuous
tubular lumen. The phenotype involves a loss of negative
Fig. 6. Interactions between DN RTK mutants and elevated MAP kinase
signaling. (A) An enhanced phenotype was produced by expressing Phl-CA in
the Ptp4E Ptp10D background. This enhancement was suppressed back to the
strength of unmodified Ptp4E Ptp10D by Egfr-DN (B) and Btl-DN (C). Pvr-DN
produced weaker suppression (D). In all panels, arrowheads indicate the
positions of TC/LT junctions. (E) Quantitative analysis of enhancement and
suppression of TC/LT phenotypes by Phl-CA alone and combined with DN
RTK mutant constructs. Scale bar: 20 mm.
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regulation of the Egfr RTK, and Ptp10D physically associates
with Egfr (Jeon and Zinn, 2009).
One of the mammalian Ptp4E/Ptp10D orthologs, PTPRJ (DEP-
1), is a direct regulator of multiple growth factor receptor TKs
(Arora et al., 2011; Berset et al., 2005; Chabot et al., 2009;
Lampugnani et al., 2003; Kappert et al., 2007; Palka et al., 2003;
Tarcic et al., 2009). This led us to test the hypothesis that Btl and
Pvr, the other two Drosophila growth factor receptor TK
orthologs that are expressed in embryonic tracheae, are also
required for the Ptp4E Ptp10D phenotype.
A quantitative analysis of cyst size at the TC/LT junction
showed that tracheally expressed DN mutants of Egfr, Btl, and
Pvr all suppress the Ptp4E Ptp10D phenotype almost to wild-
type, suggesting that dysregulation of all three RTKs is required
for the replacement of linear tubes by spherical cysts. Also, CA
mutants of each RTK enhance the phenotype, producing enlarged
cysts. These effects cannot be produced by all RTKs, since
expression of a CA mutant of InR did not enhance the phenotype
(Fig. 1O).
If the Ptp4E Ptp10D cyst phenotype is the consequence of
simultaneous deregulation of all three RTKs, it might be possible
to generate the phenotype in a wild-type background by
expressing multiple RTK CA mutants. This did not work, even
when we expressed all three CA mutants at once. Possible
explanations include: 1) because PTP activity normally
dominates over RTK activity, the effect on PTyr levels of
removing negative regulation by the RPTPs is much greater than
that produced by expressing CA RTK mutants in the presence of
the RPTPs; 2) other TKs are important for the phenotype, and
their activities must also be increased; 3) the RPTPs have PTP-
independent activities as adhesion molecules, and generation of
the phenotype requires both elevation of RTK activity and the
absence of the PTP-independent functions of the RPTPs.
We investigated whether Ptp4E and Ptp10D both regulate all
three RTKs. If they have specificity for particular RTKs, one
might be able to generate the cyst phenotype by removing only
one RPTP in the presence of a CA RTK mutant. We made such
combinations for Egfr (Ptp4E, Btl.Egfr-CA and Ptp10D,
Btl.Egfr-CA), but neither of them had cysts (M.J.,
unpublished). Since the PTP domains of Ptp4E and Ptp10D are
89% identical, it is likely that they have the same enzymatic
targets. The idea that the RPTPs have redundant functions is also
consistent with the observation that Ptp4E and Ptp10D single
mutants have no detectable phenotypes, while the double mutant
is lethal and has both tracheal (Jeon and Zinn, 2009) and nervous
system defects (Jeon et al., 2008).
Models for RTK function in tube formation
When we expressed each of the DN RTK mutants together with a
CA mutant of one of the other RTKs in the Ptp4E Ptp10D
background, the DN mutant was now unable to suppress the
phenotype back to wild-type. Instead the phenotype returned to
the strength of unmodified Ptp4E Ptp10D mutants (Fig. 1P). This
shows that if the activity of one RTK is sufficiently elevated, it
Fig. 7. Rho family GTPase signaling is required for cyst formation in
Ptp4E Ptp10D mutants. (A–C) Expression of DN Rho1 and Rac1 mutants in
wild-type (w1118) embryos produced defects in tracheal branching, including
failures of GB extension (B,C, arrows). In the Ptp4E Ptp10D background (D),
expression of Rho1-DN (E) or Rac1-DN (not shown) produced complete
suppression of the TC/LT diameter phenotype, and partial suppression of the
GB cyst number phenotype. Cdc42-DN (F) and Rho1 dsRNA (not shown)
produced partial suppression of the TC/LT phenotype, but did not affect GB
cyst number. In all panels, arrowheads indicate the positions of TC/LT
junctions. (G,H) Quantitative analysis of TC/LT (G) and GB cyst number
(H) phenotypes. Scale bar: 10 mm.
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can replace the requirement for another RTK. Thus, none of the
three RTKs is uniquely required to generate the phenotype.
Rather, the formation of tubes vs. cysts is controlled by the total
amount of activity of certain RTKs in tracheal cells. This implies
that the downstream pathways whose increased activity causes
cyst formation use SH2-domain effectors that can bind to PTyr
sites on any of the three RTKs.
It is interesting that the three RTKs can substitute for each
other in regulating the tube vs. cyst decision when they are
deregulated by loss of the RPTPs, since the RTKs do not seem to
have interchangeable activities in wild-type tracheal cells (or in
other tissues). Loss or gain of Btl function produces defects in
primary, secondary, and terminal tracheal branching (Kla¨mbt et
al., 1992; Lee et al., 1996; Reichman-Fried and Shilo, 1995;
Samakovlis et al., 1996). Loss of Egfr function produces a much
more subtle tracheal phenotype affecting tissue integrity.
Maintenance of tissue integrity requires signaling through the
MAP kinase pathway downstream of Egfr, but is unaffected by
reduction of MAP kinase signaling downstream of Btl (Cela and
Llimargas, 2006).
These findings can be explained by the fact that growth factor
receptor TKs are usually in an inactive state, due to insufficient
levels of ligands and to negative regulation by PTPs. They
become active only when they come into contact with elevated
levels of their ligands at specific times and places. The activities
of Type III RPTPs that dephosphorylate the RTKs might also be
transiently reduced at some of these times and places, possibly
through interactions of their XC domains with as yet unidentified
ligands. As a consequence of the tight control of RTK activity,
only those downstream signaling pathways that are most
responsive to a particular RTK are likely to be activated by
that RTK at any time in wild-type embryos, and the outcomes of
signaling through these pathways may also be controlled by the
subcellular distributions of ligands, RTKs, RPTPs, and
downstream effectors. By contrast, in the absence of Ptp4E and
Ptp10D, basal levels of RTK ligands may be able to drive all of
the growth factor RTKs to a high level of activity, resulting in
strong signaling through all of the downstream pathways they can
control. Loss of negative regulation might also cause
delocalization of signaling, so that effectors whose activity is
normally restricted to particular parts of the cell become
activated in a cell-wide manner. Under these conditions, a
reduction in the activity of any one of the RTKs by a DN mutant
will decrease signaling through multiple downstream pathways.
Adding a CA mutant of another RTK can then turn signaling
through all of these pathways back up, compensating for the
effects of the DN mutant.
The ability of RTKs to substitute for each other in control of
cyst formation is conceptually similar to cell transformation
through elevation of RTK signaling. RTK activity in cultured
cells is tightly controlled, and only a few endogenous RTKs are
normally involved in cellular responses to the mitogenic growth
factors in their culture medium. Many RTKs can signal through
the Ras/MAP kinase pathway, however, and elevated Ras/MAP
kinase transduction is sufficient to cause transformation of
established cell lines. Thus, oncogenic (CA) mutants of a variety
of RTKs are able to transform fibroblastic cell lines when
expressed at high levels, regardless of whether the endogenous
versions of the RTKs are normally used to regulate proliferation
in those cell lines (or are even expressed there).
Our observations on the interchangeability of the RTKs
suggests that the decision to form cysts rather than tubes in
Ptp4E Ptp10D mutants is very sensitive to the levels of PTyr on
the effector binding sites on autophosphorylated RTKs, and that
cysts appear when total PTyr rises above a critical threshold. This
conclusion is based on the complete suppression of the Ptp4E
Ptp10D cyst phenotype that is produced by expression of any of
the three DN mutants, even though each DN would eliminate
only about 1/3 of total PTyr on the RTKs, if they have roughly
equal activities. In wild-type embryos, negative regulation by the
RPTPs keeps RTK signaling well below this threshold, so the
system is insulated against random fluctuations in
phosphorylation or downstream signaling.
The Ptp4E Ptp10D GB cyst number phenotype is completely
suppressed by Btl-DN, but not suppressed at all by Egfr-DN and
only slightly by Pvr-DN. This might be taken as evidence that
elevation of Btl activity is uniquely required to replace GB tubes
with cysts. However, when Btl-DN is competed against Pvr-CA,
it is only able to suppress the Ptp4E Ptp10D, Btl.Pvr-CA
phenotype back to that of unmodified Ptp4E Ptp10D, indicating
that Btl can be replaced by Pvr if its activity is sufficiently
elevated (Fig. 2F). These findings can be explained if Btl activity
is much higher than Egfr or Pvr activity in GB cells, so that a DN
mutant that knocks down endogenous Btl activity by a DN
mutant has a greater effect on phosphorylation of effector binding
sites than mutants that reduce Egfr or Pvr activities. The activity
of CA RTK mutants is independent of the endogenous levels of
Fig. 8. Enhancement of the Ptp4E Ptp10D cyst phenotype by elevation of
Rho activity. (A) Rho1-CA expression in a wild-type (w1118) background
produced strong tracheal morphogenesis defects, including loss of
intersegmental fusion of the DT (arrows) and LT (arrowheads). (B) Rho1-CA
expression in the Ptp4E Ptp10D background converted the TC/LT region into
bubble-like structures (arrows). Cysts were present on most DBs
(B,C, arrowheads) (see also Fig. 3E). (D,E) Visualization of LT bubble
networks at higher magnification, using double-staining with anti-Crumbs
(apical marker; green) and anti-E-cadherin (junctional marker; magenta/white).
(E) shows that adherens junction markers were present within some of the
bubbles. (F–H) When DN RTKs were expressed together with Rho1-CA in
Ptp4E Ptp10D embryos, the TC/LT regions still had abnormal morphologies
like those in (B). Arrows in (F) and (H) indicate DB cysts in Egfr-DN and Pvr-
DN-expressing embryos. Scale bars for (A,B,F–H): 20 mm; for (C–E): 10 mm).
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RTKs, so the Pvr CA mutants could still reverse the effect of Btl-
DN even if Pvr-DN has no effect on its own.
The MAP kinase and Rho GTPase pathways are involved in
tube formation
To evaluate whether the MAP kinase signaling pathway is
involved in the determination of tube geometry, we expressed a
CA mutant of Phl, the Drosophila Raf kinase, in the Ptp4E
Ptp10D background. Phl-CA enhances the TC/LT phenotype
almost as strongly as Egfr-CA (Fig. 6A,E). When Phl-CA is
combined with Egfr or Btl DN mutants, the phenotype is
suppressed back to that of unmodified Ptp4E Ptp10D. Since these
RTKs are upstream of Raf, the fact that suppression occurs
suggests that pathways other than the MAP kinase pathway are
required to generate the phenotype. However, these other
pathways may be stimulated by elevation of MAP kinase
signaling, since one would expect suppression back to a near-
wild-type phenotype if they were completely independent of the
MAP kinase pathway.
We tested the involvement of Rho GTPases by expressing DN
mutants of Rho1, Rac1, and Cdc42 in the Ptp4E Ptp10D
background. Rho1-DN and Rac1-DN completely suppress the
TC/LT phenotype, and Cdc42-DN and a tracheally expressed
Rho1 RNAi construct produces partial suppression (Fig. 7G).
The DN mutant data do not necessarily show that Rho and Rac
are both required for generation of the phenotype. DN mutants
may occlude binding of wild-type Rho family GTPases to their
GEFs, some of which can act on both Rho and Rac. Therefore
high-level expression of Rac-DN might inhibit Rho activation,
and vice versa. However, the suppression of the TC/LT
phenotype by Rho1 RNAi, which is a specific inhibitor,
implicates Rho1 itself in the phenotype. Rho1-CA enhances the
Ptp4E Ptp10D phenotype, producing cysts on most DBs
(Figs 3B, 8C).
The differences in the abilities of the three RTK DN mutants to
suppress the effects of Phl-CA and Rho-CA may provide clues to
the pathways that act downstream of these kinases. The MAP
kinase and Rho pathways are not necessarily independent, since
Ras/MAP kinase pathway activation can increase Rho-GTP in
some cell lines (Sahai et al., 2001). Also, each of the three RTKs
is likely to activate both pathways to some extent, as well as
many other downstream pathways. Defining the specific outputs
of the MAP kinase and Rho pathways that control tracheal tube
geometry and identifying other RTK pathways that regulate tube
formation is likely to require genome-wide screens for
suppressors and enhancers of the Ptp4E Ptp10D phenotype.
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